All Curated Mutation Sites in HBV

The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HBV related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.

Browse Data by Virus Gene/Protein/Region, Disease OR Description

*Please select one option you are interested in, the page will be automatically redirected.

Virus Gene/Protein

Disease

Description

For highly variable viruses (e.g., HBV, HIV, SARS-CoV-2), ViMIC defaults to displaying mutations in a specific region. Click the green button to search for other regions, or click "Show All" to view all mutations (loading speed may be affected by network conditions).

Show All

BCP

Core Promoter

Core Upstream Regulatory Sequence

Keyword: Carcinoma, Hepatocellular-20419326

ID	PMID	Mutation	Gene/Protein/Region	Encoding Gene/Protein	Disease	Description	Detail
1	20419326	A2964C	PreS	S	Liver Cirrhosis Carcinoma, Hepatocellular	S C L	View
2	20419326	C2964A	PreS	S	Liver Cirrhosis Carcinoma, Hepatocellular	G S C L	View
3	20419326	C3116T	PreS	S	Liver Cirrhosis Carcinoma, Hepatocellular	G S C L	View
4	20419326	C7A	PreS	S	Liver Cirrhosis Carcinoma, Hepatocellular	G S C L	View
5	20419326	T3116C	PreS	S	Liver Cirrhosis Carcinoma, Hepatocellular	G S C L	View
6	20419326	A2962G	PreS	S	Liver Cirrhosis Carcinoma, Hepatocellular	G S C L	View
7	20419326	A3120T	PreS	S	Liver Cirrhosis Carcinoma, Hepatocellular	G S C L	View
8	20419326	C2875A	PreS	S	Liver Cirrhosis Carcinoma, Hepatocellular	G S C L	View
9	20419326	G2950A	PreS	S	Liver Cirrhosis Carcinoma, Hepatocellular	G S C L	View
10	20419326	G2951A	PreS	S	Liver Cirrhosis Carcinoma, Hepatocellular	G S C L	View
11	20419326	T3066A	PreS	S	Liver Cirrhosis Carcinoma, Hepatocellular	G S C L	View
12	20419326	T3069G	PreS	S	Liver Cirrhosis Carcinoma, Hepatocellular	G S C L	View
13	20419326	T53C	PreS	S	Liver Cirrhosis Carcinoma, Hepatocellular	G S C L	View
14	20419326	C2875T	PreS	S	Liver Cirrhosis Carcinoma, Hepatocellular	G S C L	View
15	20419326	A2951G	PreS	S	Liver Cirrhosis Carcinoma, Hepatocellular	G S C L	View
16	20419326	G2962A	PreS	S	Liver Cirrhosis Carcinoma, Hepatocellular	G S C L	View
17	20419326	G3069T	PreS	S	Liver Cirrhosis Carcinoma, Hepatocellular	G S C L	View
18	20419326	T3120A	PreS	S	Liver Cirrhosis Carcinoma, Hepatocellular	G S C L	View
19	20419326	A3054C	PreS	S	Liver Cirrhosis Carcinoma, Hepatocellular	G S C L	View
20	20419326	A3054T	PreS	S	Liver Cirrhosis Carcinoma, Hepatocellular	G S C L	View
21	20419326	C3060A	PreS	S	Liver Cirrhosis Carcinoma, Hepatocellular	G S C L	View
22	20419326	C3060T	PreS	S	Liver Cirrhosis Carcinoma, Hepatocellular	G S C L	View
23	20419326	C76A	PreS	S	Liver Cirrhosis Carcinoma, Hepatocellular	G S C L	View
24	20419326	C76T	PreS	S	Liver Cirrhosis Carcinoma, Hepatocellular	G S C L	View
25	20419326	G105C	PreS	S	Liver Cirrhosis Carcinoma, Hepatocellular	G S C L	View
26	20419326	G105T	PreS	S	Liver Cirrhosis Carcinoma, Hepatocellular	G S C L	View
27	20419326	G147C	PreS	S	Liver Cirrhosis Carcinoma, Hepatocellular	G S C L	View
28	20419326	G3191A	PreS	S	Liver Cirrhosis Carcinoma, Hepatocellular	G S C L	View
29	20419326	G3191C	PreS	S	Liver Cirrhosis Carcinoma, Hepatocellular	G S C L	View
30	20419326	T3066C	PreS	S	Liver Cirrhosis Carcinoma, Hepatocellular	G S C L	View
31	20419326	T49A	PreS	S	Liver Cirrhosis Carcinoma, Hepatocellular	G S C L	View
32	20419326	T49G	PreS	S	Liver Cirrhosis Carcinoma, Hepatocellular	G S C L	View
33	20419326	A2875C	PreS	S	Liver Cirrhosis Carcinoma, Hepatocellular	G S C L	View
34	20419326	C2946G	PreS	S	Liver Cirrhosis Carcinoma, Hepatocellular	G S C L	View
35	20419326	C53T	PreS	S	Liver Cirrhosis Carcinoma, Hepatocellular	G S C L	View

Contents
Description

The table shows all curated mutation sites of HBV in each literature

Table Description Column Note

D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.

G
The study mentioned the virus genotype/subtype information.

R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.

S
The study provided sequence information or accession numbers.

L
The study provided the geographic region/country of data origin.

C
The study provided clinical baseline information.

I
The study involved information related to immune.

T
The study involved host target genes.